Last updated: May 29, 2026

Application No. 18/250,754

GASTRORETENTIVE PHARMACEUTICAL DOSAGE FORM

Final Rejection

Filed

Apr 27, 2023

Priority

Oct 30, 2020 — CN PCT/CN2020/125319 +2 more

Examiner

BECKHARDT, LYNDSEY MARIE

Art Unit

1613

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Triastek, Inc.

OA Round

2 (Final)

This examiner grants 28% of cases after interview

— +48.7% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 556 resolved cases, 2023–2026

Examiner Intelligence

BECKHARDT, LYNDSEY MARIE View full profile →

Grants only 28% of cases

Career Allowance Rate

157 granted / 556 resolved

-31.8% vs TC avg

Strong +49% interview lift

Without

With

+48.7%

Interview Lift

resolved cases with interview

Typical timeline

3y 11m

Avg Prosecution

66 currently pending

Career history

642

Total Applications

across all art units

Statute-Specific Performance

§101

0.1%

-39.9% vs TC avg

§103

66.4%

+26.4% vs TC avg

§102

2.6%

-37.4% vs TC avg

§112

2.1%

-37.9% vs TC avg

Black line = Tech Center average estimate • Based on career data from 556 resolved cases

Prosecution Timeline

Apr 27, 2023

Application Filed

Dec 05, 2025

Non-Final Rejection mailed

Apr 03, 2026

Response Filed

May 21, 2026

Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/230,195

Patent 12534702

ELECTROACTIVE BIOCOMPATIBLE HYDROGEL STRUCTURES

4y 9m to grant Granted Jan 27, 2026

17/250,042

Patent 12458589

IMPLANTABLE POLYMER DEPOTS FOR THE CONTROLLED RELEASE OF THERAPEUTIC AGENTS

4y 11m to grant Granted Nov 04, 2025

17/055,046

Patent 12440604

BONE REGENERATION IN COMPROMISED WOUNDS

4y 11m to grant Granted Oct 14, 2025

18/552,411

Patent 12415019

BIOFLEXIBLE ELASTOMER INTESTINAL ANASTOMOSIS STENT BASED ON PTMC-B-PEG-B-PTMC COPOLYMER, AND PREPARATION METHOD

1y 11m to grant Granted Sep 16, 2025

18/078,333

Patent 12383622

Pre-Mixed, Ready-To-Use Pharmaceutical Compositions

2y 8m to grant Granted Aug 12, 2025

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4

Expected OA Rounds

28%

Grant Probability

77%

With Interview (+48.7%)

3y 11m (~10m remaining)

Median Time to Grant

Moderate

PTA Risk

Based on 556 resolved cases by this examiner. Grant probability derived from career allowance rate.